Arctic Vision to Present in the 39th Annual J.P. Morgan Healthcare Conference
2021-01-04

Shanghai, China, January 4, 2021Arctic Vision, a clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, today announced that Dr. Eddy Wu, founder and CEO of Arctic Vision, will participate in the 39th Annual J.P. Morgan Healthcare Conference in January 2021. Further details as below:


39th Annual J.P. Morgan Healthcare Conference

One on one meeting: January 13 and 14, 2021 CST

Participant: Dr. Eddy Wu, Founder & CEO of Arctic Vision

For more information, please consult your J.P. Morgan representative.

 

About Arctic Vision

Arctic Vision is a China-based clinical stage specialty ophthalmology company with a leading portfolio of breakthrough technologies. The company’s vision is to address ophthalmology’s unmet needs through innovative therapies in China, Asia and globally. Arctic Vision is established by top-tier life sciences investors, and led by an elite team of ophthalmic industry veterans with substantial and compelling China and global experiences in R&D and commercialization of eye care products. For more information, please visit www.arcticvision.com, or follow us on WeChat: ArcticVision.




ADDRESS
Suite 1732, 17F, Tower 1, Century Link, 1198 Century Avenue, Pudong New District, Shanghai, China
SUBSCRIBE TO OUR NEWSLETTER
Subscribe
Copyright © 2020 Arctic Vision (Shanghai) Biotechnology Co., Ltd.